Results 31 to 40 of about 62 (61)

[Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the ACE2 gene, and therapy with RAS blockers on the severity of COVID-19]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Zuraeva ZT   +8 more
europepmc   +1 more source

[Time-restricted eating as a novel strategy for treatment of obesity and it's comorbid conditions]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2022
Berkovskaya MA   +3 more
europepmc   +1 more source

[Semaglutide - effectiveness in weight loss and side effects when used according to studies by SUSTAIN, PIONEER, STEP]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Shabutdinova OR   +10 more
europepmc   +1 more source

[Activation markers of the stress system in patients with type 1 diabetes during hypoglycemia]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Karamullina RA   +5 more
europepmc   +1 more source

[Remote glycemic control using devices for wireless data transmission in children with type 1 diabetes mellitus: interim results of clinical approbation]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Laptev DN   +8 more
europepmc   +1 more source

[Summary of the 2023 European Society of Cardiology clinical guidelines on the management of cardiovascular disease in patients with diabetes mellitus]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Erlikh AD   +8 more
europepmc   +1 more source

[Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Shlyakhto EV   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy